
SBI Life Insurance Company Limited reported its reviewed financial results for the quarter ended June 30, 2026, posting strong growth across key financial and business indicators.
SBI Life Insurance announced its reviewed financial results for the quarter ended June 30, 2026, reporting broad-based growth in profit, premium collections, and key business metrics.
Profit After Tax (PAT) increased 22% year-on-year to 7.2 billion rupees from 5.9 billion rupees in Q1 FY26. The company also reported a 29% increase in Value of New Business (VoNB) to 14.1 billion rupees and a 36% rise in Annualized Premium Equivalent (APE) to 53.8 billion rupees, reflecting healthy growth in new business.
Gross Written Premium (GWP) grew 20% to 212.9 billion rupees, supported by 23% growth in New Business Premium and 17% growth in Renewal Premium. Individual Rated Premium (IRP) increased 14% to 39.7 billion rupees, enabling the company to maintain a 22.2% private market share.
SBI Life Insurance Company Limited is one of India's leading private life insurers, promoted by the State Bank of India and BNP Paribas Cardif. The company offers a wide range of life insurance products, including protection, savings, retirement, and annuity solutions, and is listed on both the BSE and NSE.
Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI, and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors. Choice Equity Broking Private Limited: SEBI Reg No. Broking - INZ000160131 ( BSE - 3299 ) | ( NSE - 13773 ) | ( MSEI - 73200 ) | ( MCX - 40585 ) | ( NCDEX - 01006 ). Depository Participant SEBI Reg. No. - IN - DP - 84 - 2015, DP ID CDSL - 12066900, NSDL ID - IN301895. Research Analyst - INH000000222 (CIN. NO.: U65999MH2010PTC198714)

ZF Steering Gear (India) Limited announced its financial results for the quarter ended June 30, 2026 (Q1 FY27) and approved a revision in the project cost of its wholly owned subsidiary's aluminium project. The Board increased the project's estimated investment from Rs 100 crore to Rs 150 crore to support capacity expansion and additional value-added manufacturing facilities.

Fineotex Chemical Limited announced its unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27), reporting strong growth in revenue and profitability. The performance was supported by the integration of CrudeChem Technologies Group, operational efficiencies, and capacity expansion.

Lykis Limited has postponed the Board of Directors meeting that was scheduled on Friday, July 24, 2026, to consider and approve the unaudited Standalone and Consolidated Financial Results for the first quarter ended June 30, 2026 (Q1 FY27). The company said the meeting was postponed due to the non-availability of directors, and the revised meeting date will be announced later.